{"DataElement":{"publicId":"2688806","version":"1.1","preferredName":"Stage Prognostic Factor Collaborative Staging Regional Lymph Node Code","preferredDefinition":"Records how the code for CS Lymph Nodes [2830] was determined, based on the diagnostic methods employed.","longName":"2688804v1.0:2647624v1.0","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"2688804","version":"1","preferredName":"Stage Prognostic Factor Collaborative Staging Regional Lymph Node","preferredDefinition":"Belongs to the set of Collaborative Staging (CS) data items effective with 2004 diagnosis.","longName":"2688190v1.0:2688802v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2688190","version":"1","preferredName":"Stage Prognostic Factor","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.:The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","longName":"C16899:C18959","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prognostic Factor","conceptCode":"C18959","definition":"The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C0FC8A1-D62E-5124-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-09","modifiedBy":"ONEDATA","dateModified":"2007-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2688802","version":"1","preferredName":"Collaborative Staging Regional Lymph Node","preferredDefinition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).:Regional; limited to a particular location or area.:A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph glands filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called a lymph node.","longName":"C62575:C25643:C12745","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collaborative Staging","conceptCode":"C62575","definition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Regional","conceptCode":"C25643","definition":"Of or belonging to a broader area or region of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymph Node","conceptCode":"C12745","definition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C3D0614-DE74-6B13-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-11","modifiedBy":"ONEDATA","dateModified":"2007-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C3D0614-DE85-6B13-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2647624","version":"1","preferredName":"Collaborative Staging Regional Lymph Node Code","preferredDefinition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits)._Regional; limited to a particular location or area._.]__Small, bean-shaped organs located along the channels of the lymphatic system. The lymph nodes store special cells that can trap bacteria or cancer cells traveling through the body in lymph. Clusters of lymph nodes are found in the underarms, groin, neck, chest, and abdomen. Also called lymph glands._The activity of implementing rules that are used to map the elements of one set onto the elements of another set, usually on a one-to-one basis. (from Wikipedia)_A system of numbered categories for representation of data.  [Explanatory Comment: See the Collaborative Staging Manual and Coding Instructions, Verision 1.0, for site-specific codes and coding rules.]","longName":"2647624v1.0","context":"PS-CC","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435030","version":"1","preferredName":"NCI Administrative Concept","preferredDefinition":"Conceptual entities required by NCI operations and systems. Includes administrative, financial, organizational and quasi-scientific concepts required for NCI operations and systems. ","longName":"C28389","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432182-1611-25E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2647623","version":"1","preferredName":"Collaborative Staging Regional Lymph Node Code","preferredDefinition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).:Regional; limited to a particular location or area.:A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph glands filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called a lymph node.:A system of numbered categories for representation of data.","longName":"C62575:C25643:C12745:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collaborative Staging","conceptCode":"C62575","definition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Regional","conceptCode":"C25643","definition":"Of or belonging to a broader area or region of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lymph Node","conceptCode":"C12745","definition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"324208BA-2C7D-4F7E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-06","modifiedBy":"ONEDATA","dateModified":"2007-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"324208BA-2C8E-4F7E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-05","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-06","modifiedBy":"CURTIST","dateModified":"2010-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"5899845","version":"1","longName":"StageProgFactors16","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"},{"publicId":"7464319","version":"1","longName":"StageProgFactors18","context":"PS-CC"}]}],"AlternateNames":[{"name":"CS Reg Nodes Eval","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"CS Regional Nodes Evaluation","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"2840","type":"NAACCR Item #","context":"PS-CC"},{"name":"CS LYMPH NODE EVAL","type":"NAACCR Item Name","context":"PS-CC"},{"name":"CS Lymph Nodes Eval","type":"NAACCR Item Name","context":"PS-CC"}],"ReferenceDocuments":[{"name":"Collaborative Staging Regiona","type":"Preferred Question Text","description":"Collaborative Staging Regional Node Evaluation","url":null,"context":"PS-CC"},{"name":"Cs Reg Node Eval Description","type":"COMMENT","description":"This data item is used in CS to identify whether the N (of AJCC TNM) was clinically or pathologically diagnosed and by what method \"CS Reg Nodes Eval\" is used to derive the Derived AJCC N Descriptor [2970].","url":null,"context":"PS-CC"},{"name":"Collaborative Staging (CS) Reference Manuals","type":"REFERENCE","description":"The Collaborative Stage Data Collection System (CS) Web pages serve as the main repository for CS-related items including coding instructions, software, and education and training resources for cancer registrars and cancer registry software vendors","url":"http://www.cancerstaging.org/cstage/manuals.html","context":"PS-CC"},{"name":"SEER Coding and Staging Manuals","type":"REFERENCE","description":"Coding and Staging Manuals for the Surivellance Epidemiology and End Results Program","url":"http://seer.cancer.gov/tools/codingmanuals/index.html","context":"PS-CC"},{"name":"AJCC Cancer Staging Manual","type":"REFERENCE","description":"See the AJCC Cancer Staging Manual, current edition, for site-specific categories for the TNM elements and stage groups.","url":null,"context":"PS-CC"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8B1BBC-2921-8F0E-E040-BB89AD4364FD","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-22","modifiedBy":"HARTLEYG","dateModified":"2018-11-06","changeDescription":"09/22/2011 - tc - Updated definition as per V12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}